Pharmaceuticals - Licensing/IP Transactions

Venable’s licensing attorneys represent licensors and licensees in simple and complex transactions involving a myriad of technologies. Venable attorneys provide the counseling, drafting and negotiation skills our clients expect for concluding biological material transfer agreements, bioinformatics software subscription agreements, patent licenses for emerging technologies and trademark licenses. We also handle complex inter-institutional research collaborations, sponsored research agreements and related technology transfer transactions, as well as such routine matters as assignments, confidentiality agreements and consulting and employment agreements.

Pharmaceutical industry clients’ interaction with public research and academic institutions presents challenging issues in licensing, ownership and confidentiality, requiring diplomacy and ingenuity. For many years, Venable has represented academic and research institutions, including Princeton, Johns Hopkins, Yale, McGill, the University of Maryland, the University of California, the Smithsonian Institution and the British Royal Botanical Gardens. Venable understands the financial dimensions of the bioscience industry from its representation of numerous companies in complex transactions around the globe, both in public-private arrangements with research institutions and in private-private deals with other companies.